Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Armand

Showing results (21-30 of 240) with videos related to

Pageof 24
Sort By:
Inorganic Chemistry|August 31, 2011
Growth of piezoelectric water-free GeO2 and SiO2-substituted GeO2 single-crystalsA Lignie, P Armand, P Papet
European Journal of Cancer (Oxford, England : 1990)|August 19, 2004
Procarbazine in haematology: an old drug with a new life?M Massoud, J P Armand, V Ribrag
The Journal of Infusional Chemotherapy|July 1, 1996
CPT-11: the European clinical developmentC Terret, C Couteau, J P Armand
Drugs|December 29, 2000
Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapyE Raymond, S Faivre, J P Armand
La Revue Du Praticien|May 15, 1994
[Suramin. A new role for an old drug]P Soulie, E Cvitkovic, J P Armand
Journal of Environmental Radioactivity|October 1, 2013
Chernobyl and Fukushima nuclear accidents: what has changed in the use of atmospheric dispersion modeling?Y Benamrane, J-L Wybo, P Armand
Cancer Treatment and Research|January 1, 1989
Nasopharyngeal cancer, undifferentiated type: the medical oncologist's viewpointE Cvitkovic, H Boussen, J P Armand
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|January 28, 1974
[In vitro inhibition of the blastogenesis of T lymphocytes by delta 9 tetrahydrocannabinol]G Nahas, J P Armand, J Hsu
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2015
Pharmacokinetic and pharmacodynamic end points with anti-VEGFR: the more it hurts, the more it works?O Mir, S Dumont, J-P Armand
Therapie|November 7, 1998
[Recommendations for the study of drug combination therapy for the treatment of AIDS and cancer. Round Table No 7 at Giens XIII]J P Armand, J Dormont, A Schwebig
Pageof 24

Showing results (21-30 of 240) with videos related to

Sort By:
Pageof 24
Inorganic Chemistry|August 31, 2011
Growth of piezoelectric water-free GeO2 and SiO2-substituted GeO2 single-crystalsA Lignie, P Armand, P Papet
European Journal of Cancer (Oxford, England : 1990)|August 19, 2004
Procarbazine in haematology: an old drug with a new life?M Massoud, J P Armand, V Ribrag
The Journal of Infusional Chemotherapy|July 1, 1996
CPT-11: the European clinical developmentC Terret, C Couteau, J P Armand
Drugs|December 29, 2000
Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapyE Raymond, S Faivre, J P Armand
La Revue Du Praticien|May 15, 1994
[Suramin. A new role for an old drug]P Soulie, E Cvitkovic, J P Armand
Journal of Environmental Radioactivity|October 1, 2013
Chernobyl and Fukushima nuclear accidents: what has changed in the use of atmospheric dispersion modeling?Y Benamrane, J-L Wybo, P Armand
Cancer Treatment and Research|January 1, 1989
Nasopharyngeal cancer, undifferentiated type: the medical oncologist's viewpointE Cvitkovic, H Boussen, J P Armand
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|January 28, 1974
[In vitro inhibition of the blastogenesis of T lymphocytes by delta 9 tetrahydrocannabinol]G Nahas, J P Armand, J Hsu
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2015
Pharmacokinetic and pharmacodynamic end points with anti-VEGFR: the more it hurts, the more it works?O Mir, S Dumont, J-P Armand
Therapie|November 7, 1998
[Recommendations for the study of drug combination therapy for the treatment of AIDS and cancer. Round Table No 7 at Giens XIII]J P Armand, J Dormont, A Schwebig
Pageof 24